Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 22, 2022

View Archived Issues

LCDR regulates lysosomal function through stabilization of LAPTM5 and promotes cancer cell survival

CC40.8 antibody confers protection against SARS-CoV-2 infection

New curcumin derivatives show activity against non-small lung cancer

Chinese researchers divulge 5-HT2AR antagonists and/or melatonin MT1 and/or MT2 receptor agonists

Betta Pharmaceuticals discloses PD-1/PD-L1 interaction inhibitors

Discovery of KP-1, an antifibrotic peptide that ameliorates renal fibrosis in vivo

Chinese investigators identify Toll-like receptor antagonists

Apotex patents new antiviral compounds

Shaanxi Synthetic Pharmaceutical presents new thiobenzopyran compounds

Novel Hsp90/HDAC dual inhibitor shows antifungal activity against azole-resistant Candida albicans

RosVivo signs material transfer agreement with Lilly for RSVI-301 for diabetes

Researchers present in vitro data for GYS1 inhibitor MZE-001 in Pompe disease

APTA-1 shows promising biological effects in a coronavirus-induced acute lung injury model

Grant supports Emergex's development of synthetic T-cell vaccine candidate for Chikungunya virus

BioNTech and Medigene collaborate to develop TCR-based immunotherapies for cancer

NovoBiome and Inserm collaborate on intestinal organoid-on-a-chip technology

Engineered Wnt ligands repair BBB in neuro disorders

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
In 2025, science’s biggest story was political
BioWorld
In 2025, science saw its breakthroughs, which BioWorld will be covering as part of our end-of-the-year wrap-up. But the biggest science story of 2025 is not about...
Conjugating ferrocene to GPX4 inhibitors to promote ferroptosis
BioWorld Science
Small molecules that induce iron-dependent oxidative cell death known as ferroptosis can be effective against tumors that are resistant to other therapies....
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...